 Events Cardiac Arrhythmia Suppression Trial CAST mortality patients open label titration double-blind therapy patient characteristics outcomes patients open label drug titration Cardiac Arrhythmia Suppression Trial CAST double-blind therapy patients placebo therapy patients therapy total mortality cardiac arrest rate baseline nonrandomized patients dissimilar patients following ways older ventricular ejection fraction use digitalis diuretic drugs antihypertensive agents use beta-adrenoceptor blocking agents frequent prior cardiac problems runs ventricular tachycardia bundle branch block matched comparison inequities account significant differences mortality rate resuscitation cardiac arrest nonrandomized patients equivalent patients Cox regression analysis factors hazard ratio arrhythmic death cardiac arrest nonrandomized patients female gender electrocardiographic events ventricular tachycardia proarrhythmia QRS complex heart block bradycardia open label titration important differences men women Cox regression model nonrandomized patients lack suppression ventricular premature depolarizations adverse events patient private physician request indication reason